HANSA BIOPHARMA

Lobbying Spend

—

Filings

Firms Hired

Active Period

2024–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	3	1
2025	—	4	1
2024	—	3	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
TARPLIN, DOWNS & YOUNG, LLC	—	10

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
Health & Human Services, Dept of (HHS)	9
HOUSE OF REPRESENTATIVES	7
SENATE	7
Veterans Affairs, Dept of (VA)	4

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	10
Budget/Appropriations	Budget/Appropriations	7

HANSA BIOPHARMA — Lobbying Disclosure | Poliscope